© 2021 All rights reserved
Datavagyanik- Your Research Partner
The global Heart Failure POC & LOC Devices Market size was $56 million in 2021 and is expected to grow at 17% CAGR during the period (2022-2025). The global Heart Failure POC & LOC Devices Market is segmented into North America, Europe, APAC & the Rest of the world. The prevalence of cardiovascular diseases is rising globally with the problem even more prominent in the developed economies. Point-of-Care (POC) testing is an approach that is far more efficient than the conventional central workstations to conduct tests. These tests are simpler to conduct and simplify the operations of a healthcare organization. Lab-on-a-chip (LOC) devices are also gaining rapid popularity as these semiconductor devices are very efficient in the testing of one or more kinds of small samples quickly and from any place.
Heart failure is one of the most prevalent cardiovascular diseases affecting above 40 million people around the globe. However, management of risk factors and improved medication has reduced the incidence of the disease, but it still offers increased mortality and morbidity risk worldwide. Increasing incidence and prevalence of heart failure is putting much extra burden on the healthcare system in terms of annual cost expenditure. Furthermore, it is also damaging the quality of life. Experts can only reduce that burden by timely and accurate diagnosis, which has become possible using newfangled heart failure POC (point-of-care) and LOC (lab-on-a-chip) devices.
The research report titled “Heart Failure POC & LOC Devices Market, Business and Opportunity Analysis” published by Datavagyanik presents a detailed analysis of the Heart Failure POC & LOC Devices Market with country-wise market statistics, qualitative insights, and market player analysis. One of the prime objectives of the report is to provide an assessment of the market potential, market revenue, growth, and business opportunities for the Heart Failure POC & LOC Devices Market in each country.
North America Heart Failure POC & LOC Devices Market size is expected to be – million and is expected to grow at a CAGR of –% during the period 2021 to 2028. US & Canada will drive most of the revenue in the region. North America has a huge chunk of the global market.
Europe Heart Failure POC & LOC Devices Market Size is expected to be—million and is expected to grow at a CAGR of –%. APAC Heart Failure POC & LOC Devices Market Size is Expected to grow at a CAGR of –.
The report analyzes Heart Failure POC & LOC Devices Market from the demand as well as the supply side. In supply-side analysis, we reach out to the Heart Failure POC & LOC Devices Market players to collect information on their portfolio, revenue, target customers, and other insights. During this process, paid interviews and surveys are conducted for obtaining and validating the data pointers. We also deep dive into the available paid industry databases, research studies, white papers, and annual reports.
As a part of our demand-side analysis, we reach out to the end-users of the Heart Failure POC & LOC Devices Market, to gauge the application areas, demand trends, and similar insights.
POC and LOC devices prove why technology is essential for advancing every field, including healthcare. For example, these newly introduced blood tests for measuring biomarkers are paving the way for accurate diagnosis of HF and estimation of its adverse events.
The rapid estimation of biomarkers has also intensified HF management, upbringing it to scales that were not even considered possible during the past decade.
Heart failure POC and LOC devices have also reduced global health expenditure. For example, in 2009, the annual financial burden on the US economy due to managing HF patients was above $10 billion.
With the latest advances in POC and LOC devices, most of the HF market has shifted towards these modern technologies, reducing the overall burden on the economy.
Portable analytical devices, also known as point-of-care (POC) devices, are the key to the rapid testing of biomarkers. More surprisingly, these devices can interpret the presence of biomarkers both in saliva and blood samples.
Myoglobin, creatine kinase, and troponin are key biomarkers these devices asses in the nick of time, leading to early diagnosis. Early diagnosis helps to take the patients toward better management which is responsible for negating lethal outcomes.
POC devices come in two formats. One is qualitative, which manifests the presence of biomarkers at high levels. In contrast, quantitative devices mainly focus on the particular numerical values for each biomarker.
Lab-on-a-chip (LOC) devices are a practical example of the latest science, including nanotechnology and microfluidics. Surprisingly, it incorporates multiple functions inside a single tiny chip.
LOC devices are also known as a miniature version of in-vitro diagnostics. Moreover, these devices are a revolution with their unlimited applications in the medical and healthcare fields. LOC devices have helped to enhance patient point of care (POC) services.
Their use is not only limited to diagnosing heart failure patients, but they are also helpful for diagnosing several infectious diseases due to their application in the rapid analysis of blood samples. In addition, they have also indicated assessing male fertility and diagnosis of certain conditions such as cancer and bipolar disease.
It’s not only that, but more modern advances such as the attachment of LOC devices to smartphones are also a great way ahead in terms of technological advancement.
The market of these devices is also segmented into different groups using parameters such as test type, technology type, end-users, and regions. Most importantly, depending on the areas, North America dominated the market and showed the highest revenue in 2020.
The report shows the fastest-growing region for heart failure LOC and POC devices in Asia. It is because of the rapidly increasing prevalence of heart disease patients in these regions. In 2020, China showed the most cases of death related to heart diseases, indicating one of the biggest targets for the LOC and POC devices market.
In 2021, the heart failure LOC and POC device market size was $56 million. But, the recent COVID pandemic has caused an increased risk of heart failure. This global growth has fueled the heart failure POC and LOC markets. The market is expected to reach $180 million by 2028.
This business analysis report on the Heart Failure POC & LOC Devices Market presents a regional as well as country-level analysis. The regions covered in the report are – North America, Europe, Asia Pacific and Rest of the World. In these four regions, all the countries have been covered in detail with information on Heart Failure POC & LOC Devices Market size, trends, and forecast.
The report covers Heart Failure POC & LOC Devices Market revenue and forecast for the period (2021 – 2028), by regions, (further split into countries):
|Heart Failure POC & LOC Devices Market Revenue ($Million)||XX||XX||XX||XX||XX||XX||XX|
*Note – Country-level break-down has been covered in the report
Some of the market players covered in the report are listed below
Proteomics Market Research Report, Analysis and Forecast – (2021 – 2028)
Metabolic Testing Market Research Report, Analysis and Forecast – (2021 – 2028)
Genomic Testing Market Research Report, Analysis and Forecast – (2021 – 2028)
“Every Organization is different and so are their requirements”- Datavagyanik
Add the power of Impeccable research, become a DV client